| Name | Title | Contact Details |
|---|
InsightRX is a healthcare technology company that has developed a platform for precision medicine and clinical analytics designed to individualize treatment at the point of care.
Picwell is a Philadelphia-based, healthcare technology company providing leading enterprise solutions to enhance healthcare benefits and improve the consumer experience. Picwell`s flagship offering is a SaaS-based decision support product that uses artificial intelligence to match individuals to the right health benefits during enrollment by predicting future care considerations, estimating out-of-pocket expenses, and accounting for individual preferences. Other solutions support consumerism and high-deductible health plan adoption, consumer engagement, and risk management. We are on a mission to transform choice in healthcare. More than 200 million people choose benefits each year, but the complexity of the healthcare system makes it challenging to get the right protection based on individual care and cost needs. We imagine a future where healthcare benefits are simple – and people can make the right choice with confidence.
Oral Surgery Partners is a practice management company that provides professional management services for leading oral diagnostic and surgical practices for any issues that affect the mouth, teeth, and facial region.
Northwest Medical Center, Inc. is a Margate, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.